Navrogen raises $3M in venture capital financing to advance cancer therapy platform
The four-year-old company also converted more than $3 million in notes into equity.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: John George Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Cancer Therapy | Health Management | Venture Capital